A
Arda Therapeutics
Taking aim at chronic diseases and aging by eliminating the pathogenic cells that drive these conditions
About Arda Therapeutics
Arda Therapeutics is a cutting-edge biotechnology startup focused on developing targeted therapies for various diseases. The company operates in the healthcare and pharmaceutical market, specifically within the niche of precision medicine. Precision medicine is a medical approach that customizes healthcare treatments to individual patients based on their unique cellular and genetic information.
Arda Therapeutics' core business revolves around the use of single-cell data to identify and target pathological cells—cells that cause disease. By analyzing data at the single-cell level, the company can pinpoint the exact cells responsible for a disease and design therapies to eliminate only those harmful cells. This targeted approach aims to increase the effectiveness of treatments while minimizing side effects, as it avoids harming healthy cells.
The primary clients of Arda Therapeutics include healthcare providers, pharmaceutical companies, and research institutions. These clients are interested in advanced therapeutic solutions that offer higher precision and better outcomes for patients.
Arda Therapeutics operates on a business-to-business (B2B) model. It generates revenue through various channels, including partnerships with pharmaceutical companies, licensing its technology, and providing specialized research services. By collaborating with larger entities in the healthcare sector, Arda can leverage its innovative technology to bring new therapies to market more efficiently.
In summary, Arda Therapeutics is a biotech startup that uses single-cell data to develop targeted therapies for diseases. It serves healthcare providers, pharmaceutical companies, and research institutions, operating in the precision medicine market. The company makes money through partnerships, licensing, and research services.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Employees
- 21
- Open positions
- None listed
- Dealroom signal
- 87.2/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotechnology, Precision Medicine, Biotech and Pharma, Hard Tech, Longevity, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- B2B
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES AOther financing | Oct 2024 | $43M | $172M | Two Sigma Ventures · Indicator Ventures · Eli Lilly · Mana Ventures | ↗ |
| EARLY VCOther financing | Jan 2022 | $7.5M | $30M | Undisclosed | — |
Growth signals
Latest recorded traffic for Arda Therapeutics is 1.5K monthly website visits, down 11.8% over the last three months. Arda Therapeutics's team grew 16.7% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Arda Therapeutics in the San Carlos ecosystem
The Arda Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A13 investors entered at this stage
Andreessen Horowitz
Two Sigma Ventures
Indicator Ventures
Eli Lilly
Mana Ventures
LifeLink Ventures
Exitfund Venture
GV
Gaingels
Alumni Ventures
Valhalla Ventures
Biovision Ventures
RV Invest
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Arda Therapeutics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Arda Therapeutics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.










